Pretax income is the income that a company earns before paying income taxes. Biodesix's pretax income for the
three
months ended in Sep. 2024 was $-10.26 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-43.82 Mil.
Biodesix's pretax margin was -56.51%.
During the past 6 years, Biodesix's highest Pretax Margin was -66.84%. The lowest was -171.27%. And the median was -115.69%.
Biodesix Pre-Tax Income Historical Data
The historical data trend for Biodesix's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biodesix's Pre-Tax Income
For the Diagnostics & Research subindustry, Biodesix's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biodesix's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Biodesix's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Biodesix's Pre-Tax Income falls into.
Biodesix Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Biodesix's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-43.82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biodesix (NAS:BDSX) Pre-Tax Income Explanation
Biodesix's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as
During the past 6 years, Biodesix's highest Pretax Margin was -66.84%. The lowest was -171.27%. And the median was -115.69%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biodesix Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Biodesix's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BDSX has been successfully added to your 